273
Views
1
CrossRef citations to date
0
Altmetric
Systematic review

Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies

ORCID Icon, , ORCID Icon &
Pages 1179-1193 | Received 14 Mar 2021, Accepted 08 Jun 2021, Published online: 20 Aug 2021

References

  • Frise CJ, Williamson C. Endocrine disease in pregnancy. Clin. Med. 2013;13(2):176–181.
  • Stagnaro-Green A. Overt Hyperthyroidism and Hypothyroidism During Pregnancy. Clin Obstet Gynecol. 2011 Sep;54(3):478–487.
  • He X, Wang P, Wang Z, et al. ENDOCRINOLOGY IN PREGNANCY: thyroid antibodies and risk of preterm delivery: a meta-analysis of prospective cohort studies. Eur J Endocrinol. 2012 Oct;167(4):455–464.
  • Negro R, Stagnaro-Green A. Thyroid autoantibodies, preterm birth, and miscarriage. BMJ. 2011May;342:d2260.
  • Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011 May;342(may09 1):d2616–d2616.
  • Chen L, Hu R. Thyroid autoimmunity and miscarriage: a meta-analysis. Clin Endocrinol (Oxf). 2011 Apr;74(4):513–519.
  • Kahaly GJ. Management of Graves Thyroidal and Extrathyroidal Disease: an Update. J Clin Endocrinol Metab. 2020;105(12):01.
  • Shinohara DR, Santos TDS, de Carvalho HC, et al. Pregnancy complications associated with maternal hypothyroidism: a systematic review. , Obstetrical & Gynecological Survey. 2018;73(4):219–230.
  • Dong AC, Stagnaro-Green A. Differences in Diagnostic Criteria Mask the True Prevalence of Thyroid Disease in Pregnancy: a Systematic Review and Meta-Analysis. Thyroid. 2019 Feb;29(2):278–289.
  • Tonacchera M, Chiovato L, Bartalena L, et al. Treatment of Graves’ hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy. J. Endocrinol. Invest. Feb 2020;43(2):257–265.
  • Rao M, Zeng Z, Zhou F, et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis. Hum Reprod Update. 2019 May;25(3):344–361.
  • Sun X, Hou N, Wang H, Ma L, Sun J, Liu Y. A Meta-Analysis of Pregnancy Outcomes With Levothyroxine Treatment in Euthyroid Women With Thyroid Autoimmunity. J Clin Endocrinol Metab. 2020;105(4). doi:https://doi.org/10.1210/clinem/dgz217
  • Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid Off. J. Am. Thyroid Assoc. 2017;27(3):315–389.
  • Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur. Thyroid J. Aug 2018;7(4):167–186.
  • AMINO N, TADA H, HIDAKA Y, et al. Postpartum autoimmune thyroid syndrome. Endocr. J. 4747:645–655. 2000
  • Stagnaro-Green A. Approach to the Patient with Postpartum Thyroiditis. J Clin Endocrinol Metab. 2012 Feb;97(2):334–342.
  • Reid SM, Middleton P, Cossich MC, et al. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy. Cochrane Database Syst Rev. May 2013. DOI:https://doi.org/10.1002/14651858.CD007752.pub3.
  • Harris B, Oretti R, Lazarus J, et al. Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br J Psychiatry. 2002 Apr;180(4):327–330.
  • Jouyandeh Z, Hasani-Ranjbar S, Qorbani M, et al. Universal screening versus selective case-based screening for thyroid disorders in pregnancy. Endocrine. 2015 Feb;48(1):116–123.
  • Vissenberg R, van den Boogaard E, van Wely M, et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2012 Jul;18(4):360–373.
  • Spencer L, Bubner T, Bain E, et al. Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health. Cochrane Database Syst Rev. 2015 Sep. DOI:https://doi.org/10.1002/14651858.CD011263.pub2
  • Thyroid Disease in Pregnancy: ACOG Practice Bulletin, Number 223. Obstet Gynecol. 2020 Jun;135(6):e261–e274.
  • Watt T, Groenvold M, Rasmussen AK, et al. Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol. 2006 Apr;154(4):501–510.
  • Watt T, Watt T, Hegedüs L, et al. Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism? Eur. Thyroid J 2012;1(3):186–192.
  • Van der Woude DAA, Pijnenborg JMA, de Vries J. Health status and quality of life in postpartum women: a systematic review of associated factors. Eur J Obstet Gynecol Reprod Biol. 2015Feb;185:45–52.
  • Lagadec N, Steinecker M, Kapassi A, et al. Factors influencing the quality of life of pregnant women: a systematic review. BMC Pregnancy Childbirth. 2018 Dec;18(1). DOI:https://doi.org/10.1186/s12884-018-2087-4.
  • Dosiou C, Barnes J, Schwartz A, et al. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab. 2012 May;97(5):1536–1546.
  • Thung SF, Funai EF, Grobman WA. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am. J. Obstet. Gynecol. 2009 Mar;200(3):267.e1–7.
  • Donnay Candil S, Balsa Barro JA, Álvarez Hernández J, et al. [Cost-effectiveness analysis of universal screening for thyroid disease in pregnant women in Spain]. Endocrinol. Nutr. Organo Soc. Espanola Endocrinol. Nutr. Sep 2015;62(7):322–330.
  • Petrou S, Rivero-Arias O, Dakin H, et al. Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: the MAPS Statement. PharmacoEconomics. 2015 Oct;33(10):985–991.
  • ‘Critical Appraisal Checklist for Analytical Cross Sectional Studies, Joanna Briggs Institute 2020; [cited 1 Jan 2021]. https://joannabriggs.org/sites/default/files/2020-08/Checklist_for_Analytical_Cross_Sectional_Studies.pdf’
  • Oretti RG, Hunter C, Lazarus JH, et al. Antenatal depression and thyroid antibodies. Biol Psychiatry. 1997 Jun;41(11):1143–1146.
  • Kuijpens J, Vader H, Drexhage H, et al. Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. Eur J Endocrinol. 2001 Nov;579–584. https://doi.org/10.1530/eje.0.1450579
  • Pedersen C, Leserman J, Garcia N, et al. Late pregnancy thyroid-binding globulin predicts perinatal depression. Psychoneuroendocrinology. 2016Mar;65:84–93.
  • Pedersen CA, Johnson JL, Silva S, et al. Antenatal thyroid correlates of postpartum depression. Psychoneuroendocrinology. 2007 Apr;32(3):235–245.
  • Bunevicius R, Kusminskas L, Mickuviene N, et al. Depressive disorder and thyroid axis functioning during pregnancy. World J Biol Psychiatry. 2009 Jan;10(4):324–329.
  • Wissart J, Parshad O, Kulkarni S. Prevalence of pre- and postpartum depression in Jamaican women. BMC Pregnancy Childbirth. 2005 Dec;5(1):15.
  • Pop V, Broeren M, Wiersinga W, et al. Thyroid disease symptoms during early pregnancy do not identify women with thyroid hypofunction that should be treated. Clin Endocrinol (Oxf). 2017 Dec;87(6):838–843.
  • Le Donne M, Settineri S, Benvenga S. Early pospartum alexithymia and risk for depression: relationship with serum thyrotropin, free thyroid hormones and thyroid autoantibodies. Psychoneuroendocrinology. 2012 Apr;37(4):519–33 doi:https://doi.org/10.1016/j.psyneuen.2011.08.001. Epub 2011 Oct 31. PMID: 22047958.
  • Harris B, Othman S, Davies JA, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ. 1992 Jul;305(6846):152–156.
  • Lazarus JH, Hall R, Othman S, et al. The clinical spectrum of postpartum thyroid disease. QJM. 1996 Jun;89(6):429–436.
  • Hayslip CC, Fein HG, O’Donnell VM, et al. The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol. 1988 Jul;159(1):203–209.
  • Kent GN, Stuckey BGA, Allen JR, et al. Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol (Oxf). 1999 Oct;51(4):429–438.
  • Albacar G, Sans T, Martín-Santos R, et al. Thyroid function 48h after delivery as a marker for subsequent postpartum depression. Psychoneuroendocrinology. 2010 Jun;35(5):738–742.
  • Bergink V, Pop VJM, Nielsen PR, et al. Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study. Psychol Med. 2018;48(8):1291–1298.
  • Groer M, Jevitt C. Symptoms and Signs Associated with Postpartum Thyroiditis. J. Thyroid Res. 2014;2014:1–6.
  • Walfish PG, Meyerson J, Provias JP, et al. Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada. J Endocrinol Invest. 1992 Apr;15(4):265–272.
  • Lambrinoudaki I, Rizos D, Armeni E, et al. Thyroid function and postpartum mood disturbances in Greek women. J Affect Disord. 2010 Mar;121(3):278–282.
  • Keshavarzi F, Yazdchi K, Rahimi M, et al. Post partum depression and thyroid function. Iran J Psychiatry. 2011;6(3):117-120.
  • McCoy SJ, Beal JM, Payton ME, et al. Postpartum thyroid measures and depressive symptomology: a pilot study. J Am Osteopath Assoc. 2008 Sep;108(9):503-7.
  • Sylvén SM, Elenis E, Michelakos T, et al. Thyroid function tests at delivery and risk for postpartum depressive symptoms. Psychoneuroendocrinology. 2013 Jul;38(7):1007–1013.
  • Synek P, Tuzil J. How to be happy: analysis based on 3,438 primary studies. 2nd ed. 2020, www.happiness-science.com,ISBN978-80-270-9275-8.
  • Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J. Gen. Intern. Med. 1997;12(9):544–550.
  • Cramon P, Bonnema SJ, Bjorner JB, et al. Quality of Life in Patients with Benign Nontoxic Goiter: impact of Disease and Treatment Response, and Comparison with the General Population. Thyroid. 2015 Mar;25(3):284–291.
  • Rasmussen SL, Rejnmark L, Ebbehøj E, et al. High level of agreement between electronic and paper mode of administration of a thyroid-specific patient-reported outcome, thypro. Eur. Thyroid J. 2016;5(1):65–72.
  • Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. 2013 Sep;22(7):1717–1727. Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil.
  • Watt T, Bjorner JB, Groenvold M, et al. Development of a Short Version of the Thyroid-Related Patient-Reported Outcome ThyPRO. Thyroid Off. J. Am. Thyroid Assoc . 2015 Oct;25(10):1069–1079.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.